Year: 2022
Type: review
Abstract: Cancer ranks as one of the deadliest diseases worldwide. The high mortality rate associated with cancer is partially due to the lack of reliable early detection methods and/or inaccurate diagnostic tools such as certain protein biomarkers. Cell-free nucleic acids (cfNA) such as circulating long noncoding RNAs (lncRNAs) have been proposed as a new class of potential biomarkers for cancer diagnosis. The reported correlation between the presence of tumors and abnormal levels of lncRNAs in the blood of cancer patients has notably triggered a worldwide interest among clinicians and oncologists who have been actively investigating their potentials as reliable cancer biomarkers. In this report, we review the progress achieved ("the Good") and challenges encountered ("the Bad") in the development of circulating lncRNAs as potential biomarkers for early cancer diagnosis. We report and discuss the diagnostic performance of more than 50 different circulating lncRNAs and emphasize their numerous potential clinical applications ("the Beauty") including therapeutic targets and agents, on top of diagnostic and prognostic capabilities. This review also summarizes the best methods of investigation and provides useful guidelines for clinicians and scientists who desire conducting their own clinical studies on circulating lncRNAs in cancer patients via RT-qPCR or Next Generation Sequencing (NGS).
Source: npj Precision Oncology
Authors: Cedric Badowski, Bing He, Lana X. Garmire
Institutions: University of Hawaii Cancer Center, University of Michigan
Language: English
Subfield: Cancer Research
Domain: Life Sciences
Open Access status: gold
Estimated APC paid: $3,390
Funders: U.S. Department of Health and Human Services, National Institutes of Health, National Institute of General Medical Sciences, National Institute of Environmental Health Sciences, U.S. National Library of Medicine, Eunice Kennedy Shriver National Institute of Child Health and Human Development
Awards: DR. EPS: Drug Repurposing for Extended Patient Survival, G1597177782, G2711154378, An Integrative Omics Approach to Identify Biomarkers Related to Preeclampsia and Breast Cancer Risks, Institute for Biogenesis Research: COBRE, An Integrative Bioinformatics Approach to Study Single Cancer Cell Heterogeneity, Cancer precision medicine through spatially informative single cell image and transcriptomics data analysis, G9000203449
OpenAlex ID: W4283219748
